| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 9.0× | −1.8× | |
| Price / Book | 2.9× | 2.1× | |
| Price / Sales | 3.3× | 4.0× | |
| Price / Free cash flow | 33.3× | −1.6× | |
| EV / EBITDA | 22.4× | −1.2× | |
| Earnings yield | 11.2% | −14.1% | |
| Free cash flow yield | 3.0% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.00 | −1.81% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.70 | −1.46% | $634.81B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.03 | −0.76% | $500.15B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.47 | −0.83% | $378.31B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.10 | −2.13% | $355.52B | 19.9× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.45 | −0.52% | $280.11B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.72 | −1.07% | $264.77B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $672.74 | −0.56% | $248.74B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $441.25 | −1.35% | $238.55B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.96 | −0.15% | $194.62B | 22.9× | 37.5% | +26.7% |
